Tag: Rigel

Posted on

Rigel drops asthma drug after trial fails, stock hits life-low – Reuters


The Denver Channel

Rigel drops asthma drug after trial fails, stock hits life-low
Reuters
(Reuters) – Rigel Pharmaceuticals Inc said it will stop developing its experimental asthma drug after the therapy failed in a mid-stage trial, sending its shares down as much as 17 percent to a life-low. The failure of the inhaled drug is the latest …
Rigel Shares Plunge After Asthma Drug Fails to Meet GoalsBloomberg
Rigel shares slide after another drug flops in PhII asthma studyFierceBiotech
Rigel Pharmaceuticals skids after asthma drug fails in studyThe Denver Channel
Wall Street Journal –PR Newswire (press release) –NASDAQ
all 30 news articles »

View full post on asthma – Google News

Posted on

Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for … – Sacramento Bee

Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for …
Sacramento Bee
SOUTH SAN FRANCISCO, Calif., Sept. 5, 2012 — /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it has commenced Phase 2 clinical studies with two of the company's most advanced proprietary therapeutic product …
Rigel commences R343 and R333 Phase 2 studies in allergic asthma, discoid …News-Medical.net
Leerink Swann Starts Rigel Pharmaceuticals (RIGL) at Outperform; Top Biotech …StreetInsider.com (subscription)

all 4 news articles »

View full post on asthma – Google News

Posted on

Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for … – The Herald | HeraldOnline.com

Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for …
The Herald | HeraldOnline.com
SOUTH SAN FRANCISCO, Calif., Sept. 5, 2012 — /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it has commenced Phase 2 clinical studies with two of the company's most advanced proprietary therapeutic product …
Rigel Pharma (RIGL) Starts Clinical Studies For Asthma, Discoid LupusiStockAnalyst
Rigel Begins Trial With Advanced Proprietary Therapeutic Product CandidatesNASDAQ

all 13 news articles »

View full post on asthma – Google News

Posted on

AstraZeneca to join Rigel in asthma drug venture – The News Journal


Proactive Investors USA & Canada

AstraZeneca to join Rigel in asthma drug venture
The News Journal
AstraZeneca will join with Rigel Pharmaceutical Inc. to develop a treatment for chronic asthma that could be worth $100 million, if the drug can manage the …
AstraZeneca partners with Rigel on asthma drugCBS News
AstraZeneca and Rigel strike asthma deal worth up to $100MFierceBiotech
AstraZeneca And Rigel Sign Worldwide License Agreement For A …MarketWatch (press release)
NASDAQ –Proactive Investors USA & Canada –RTT News
all 37 news articles »

View full post on asthma – Google News

Posted on

AstraZeneca partners with Rigel on asthma drug – CBS News

AstraZeneca partners with Rigel on asthma drug
CBS News
NEW YORK — Rigel Pharmaceuticals Inc. plans to work with AstraZeneca PLC to develop an experimental asthma drug as part of a deal that could be worth …
AstraZeneca and Rigel strike asthma deal worth up to $100MFierceBiotech
AstraZeneca And Rigel Sign Worldwide License Agreement For A …MarketWatch (press release)
AstraZeneca, Rigel to Develop Asthma TreatmentNASDAQ
Bizjournals.com (blog)
all 22 news articles »

View full post on asthma – Google News

Posted on

AstraZeneca and Rigel strike asthma deal worth up to $100M – FierceBiotech

AstraZeneca and Rigel strike asthma deal worth up to $100M
FierceBiotech
The deal hinges on Rigel's candidate known as R256, an inhalable JAK inhibitor under evaluation for treating tough cases of asthma.
AstraZeneca And Rigel Sign Worldwide License Agreement For A …MarketWatch (press release)
AstraZeneca, Rigel to Develop Asthma TreatmentNASDAQ
Rigel, AstraZeneca strike potential $100M asthma drug dealBizjournals.com (blog)

all 19 news articles »

View full post on asthma – Google News